Latest news with #IMDC
India.com
4 days ago
- Entertainment
- India.com
This blockbuster film won 55 awards, took 3 years to make, had a budget of Rs 180 crore, Rs 85 crore spent solely on VFX; lead actors are…, film is…
10 years ago, a blockbuster film dominated the box office for months. When the film was released, it created history by winning 55 awards. The audience liked the story so much that the film became a cult. The movie did business of more than Rs 600 crore worldwide. Still couldn't guess which film we are talking about? This iconic film was released with a massive budget of Rs 180 crore. Not only the story of the film, but also every visual made the audience happy. The film became a hit as soon as it hit the theatres and went on to win multiple accolades and awards, along with earning a huge amount. The name of the film we are talking about is 'Baahubali: The Beginning'. When was 'Baahubali: The Beginning' released? The Telugu film 'Baahubali: The Beginning' was released in 2015. It featured Prabhas, Rana Daggubati, Tamannaah Bhatia, Anushka Shetty, and Ramya Krishnan in lead roles. The film was directed by renowned filmmaker SS Rajamouli. What is the plot of Baahubali? This period drama film depicted the Mahishmati Empire. Its story was set in the 9th century. 'Baahubali: The Beginning' proved to be a milestone in the history of Indian cinema. Hollywood-level VFX was incorporated in the period drama film. How much money was spent on the VFX? According to the IMDb report, Prabhas' film was made for Rs 180 crore. Rs 85 crore was spent only on VFX. Every scene of the film won the hearts of the audience. 'Baahubali: The Beginning', took three years to make. The film's editing, cinematography, action choreography and production design were all top class. What made Baahubali so special? 'Baahubali: The Beginning' is the film that got India recognition worldwide. The success of this movie made Prabhas a pan-India star. The story of this film was written by none other than SS Rajamouli's father, V. Vijayendra Prasad. How much did Baahubali earn in BOC? According to the report of Sacnilk, this film of Prabhas earned Rs 516 crore in India. This includes the collection of all languages. At the same time, the total business of 'Baahubali: The Beginning' worldwide was Rs 650 crore. 'Baahubali: The Beginning' received two National Awards for Best Feature Film and Best Special Effects. According to IMDC, the film won a total of 55 awards. Prabhas 'Baahubali: The Beginning' has a rating of 8 out of 10.
Scientific American
13-05-2025
- Climate
- Scientific American
Disasters Displaced a Record 46 Million People Last Year
CLIMATEWIRE | Natural disasters and human conflict forced about 66 million people to flee within their own countries last year, and the United States led all nations with 11 million of these internal displacements, new research finds. That's a record for the United States. And last year broke a global record, too, as 2024 saw the largest number of disaster-related internal displacements since experts began tracking the issue in 2008. About 46 million people worldwide had to relocate domestically last year because of natural disasters; another 20 million had to flee because of conflict or violence. Those are the latest statistics from the Internal Displacement Monitoring Centre, an international nongovernmental organization that keeps tabs on the number of people forced to flee within their countries each year because of natural disasters, extreme weather, conflict and violence. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. IMDC publishes the previous year's findings in an annual report each spring; its latest analysis was released Tuesday. The 46 million people forced to relocate domestically because of natural disasters last year represents a big jump from 2023, which saw 26 million people internally displaced because of events such as storms, floods, wildfires and droughts. In the United States, natural disasters were the sole reason 11 million residents had to relocate domestically. Cyclones triggered more than half of disaster-related movements worldwide last year. That includes Hurricanes Helene and Milton, which both caused tens of billions of dollars of damage in the United States. Floods accounted for another 42 percent of the disaster displacements, with events occurring on every continent last year. At least 8.3 million disaster-related movements occurred in the form of preemptive evacuations, the report found. Evacuations were reported in 53 of the 163 countries and territories reporting weather and disaster displacements in 2024. Many of these occurred in the United States; Hurricane Milton alone triggered around 6 million evacuations in Florida. Climate change is causing extreme weather events to intensify globally. At the same time, the report notes, other human factors are worsening the impact of these disasters, including inadequate infrastructure and urban expansion in disaster-prone areas. Low- and middle-income countries, on the whole, continue to be disproportionately affected by disaster displacements. And vulnerable communities within these countries tend to experience the worst outcomes. For instance, catastrophic flooding in the Brazilian state of Rio Grande do Sul last spring killed more than 180 people and triggered at least 775,000 displacements. Most occurred in the state capital of Porto Alegre, according to the IDMC report, and disproportionately affected Black and Indigenous communities. At the same time, conflict zones are increasingly overlapping with areas hit hard by natural disasters, many made worse by climate change. According to the report, the number of countries reporting both disaster and conflict displacements has tripled since 2009. The rise of these compounding crises points to the need for better preparation and resilience efforts, the report suggests. 'Resolving displacement requires both immediate efforts to help people who have lost everything and investments to address underlying vulnerabilities, so people don't become displaced in the first place,' said IDMC Director Alexandra Bilak in a statement. More than 20 million people across 49 countries were internally displaced by conflict and violence last year, the report found. All but four of these countries reported disaster displacements as well. More than 5 million conflict displacements occurred in the Democratic Republic of the Congo, the most of any country worldwide. Heavy rainfall also triggered intense floods in the DRC last year, and many roads became blocked by water or by armed groups. The combination of these issues prevented aid organizations from assisting hundreds of thousands of displaced people, the report found. The report also notes that while some people are able to return home after disasters or conflict subside, many remain displaced for years. Around 65.8 million people were newly displaced in 2024 by both conflict and disasters. But millions of others already were living in displacement at the start of the year. At the end of 2024, about 83.4 million people were living in displacement worldwide. The vast majority, around 73.5 million, had been forced to move because of conflict — a 10 percent increase over the previous year. Still, disaster-related displacement is rising even faster. About 9.8 million people worldwide were living in displacement from disasters at the end of 2024 — a 29 percent increase over 2023.
Yahoo
21-02-2025
- Health
- Yahoo
ASCO GU Symposium announces new findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Feb. 20—Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the University Medical Center (UMC) Cancer Center, shared groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study. The findings underscore the critical role of tumor size reduction in improving survival outcomes for patients with advanced renal cell carcinoma (aRCC). The latest analysis, presented Feb. 13-14 at the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2025), further solidifies the effectiveness of the lenvatinib (Lenvima) and pembrolizumab (Keytruda) combination in treating this aggressive form of kidney cancer. Hutson played a key role in the study and provided insights into the impact of these findings. "This analysis reinforces that greater tumor shrinkage correlates with improved survival outcomes," Hutson said. "We now have compelling evidence that reducing overall tumor burden not only extends survival but also enhances the effectiveness of subsequent treatments, setting patients up for better long-term prognoses." The study, which initially led to the FDA approval of lenvatinib plus pembrolizumab for advanced renal cell carcinoma in 2021, continues to provide valuable insights into treatment strategies. The new findings demonstrate that patients with greater reductions in total tumor size at disease progression had significantly longer median survival rates. Additionally, data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) show that patients receiving the combination therapy were more likely to maintain or improve their IMDC risk scores, further supporting the regimen's impact on long-term survival. "These findings emphasize the importance of aggressive tumor reduction in the fight against renal cell carcinoma," Hutson added. "The data suggest that this combination therapy offers the best outcomes among currently available treatments, making it a strong contender for first-line treatment in advanced renal cell carcinoma." TTUHSC and UMC Health System remain committed to advancing cancer treatment and improving patient outcomes through innovative research and clinical excellence.
